Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för olodaterol. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

11 träffar

Bibliografisk träff 2014-08-09

The 24-h FEV1 time profile of olodaterol once daily via Respimat® and formoterol twice daily via Aerolizer® in patients with GOLD 2-4 COPD: results from two 6-week crossover studies.

Feldman GJ, Bernstein JA, Hamilton A, Nivens MC, Korducki L, LaForce C.

Springerplus · research-article; journal article · DOI 10.1186/2193-1801-3-419

Bibliografisk träff 2014-07-31

Once-daily long-acting beta-agonists for chronic obstructive pulmonary disease: an indirect comparison of olodaterol and indacaterol.

Roskell NS, Anzueto A, Hamilton A, Disse B, Becker K.

Int J Chron Obstruct Pulmon Dis · research support, non-u.s. gov't; research-article; systematic review; network meta-analysis; journal article · DOI 10.2147/copd.s59673

Bibliografisk träff 2014-07-05

Lung function efficacy and symptomatic benefit of olodaterol once daily delivered via Respimat® versus placebo and formoterol twice daily in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Koch A, Pizzichini E, Hamilton A, Hart L, Korducki L, De Salvo MC, Paggiaro P.

Int J Chron Obstruct Pulmon Dis · clinical trial, phase iii; comparative study; research support, non-u.s. gov't; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.2147/copd.s62502

Bibliografisk träff 2014-06-16

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2-4 COPD: results from two replicate 48-week studies.

Ferguson GT, Feldman GJ, Hofbauer P, Hamilton A, Allen L, Korducki L, Sachs P.

Int J Chron Obstruct Pulmon Dis · clinical trial, phase iii; research-article; multicenter study; randomized controlled trial; journal article · DOI 10.2147/copd.s61717

Bibliografisk träff 2014-01-01

Current and novel bronchodilators in respiratory disease.

Spina D.

Curr Opin Pulm Med · review; journal article · DOI 10.1097/mcp.0000000000000012

Bibliografisk träff 2013-12-04

Bronchoprotection by olodaterol is synergistically enhanced by tiotropium in a guinea pig model of allergic asthma.

Smit M, Zuidhof AB, Bos SI, Maarsingh H, Gosens R, Zaagsma J, Meurs H.

J Pharmacol Exp Ther · comparative study; research support, non-u.s. gov't; journal article · DOI 10.1124/jpet.113.208439

Bibliografisk träff 2013-11-19

Tiotropium sustains the anti-inflammatory action of olodaterol via the cyclic AMP pathway.

Costa L, Roth M, Miglino N, Keglowich L, Zhong J, Lardinois D, Tamm M, Borger P.

Pulm Pharmacol Ther · research support, non-u.s. gov't; journal article · DOI 10.1016/j.pupt.2013.11.001

Bibliografisk träff 2013-11-01

Olodaterol: first global approval.

Gibb A, Yang LP.

Drugs · review; journal article · DOI 10.1007/s40265-013-0137-9

Bibliografisk träff 2011-08-06

24-hour bronchodilation following a single dose of the novel β(2)-agonist olodaterol in COPD.

van Noord JA, Smeets JJ, Drenth BM, Rascher J, Pivovarova A, Hamilton AL, Cornelissen PJ.

Pulm Pharmacol Ther · randomized controlled trial; journal article · DOI 10.1016/j.pupt.2011.07.006

Bibliografisk träff 2010-04-06

Pharmacological characterization of olodaterol, a novel inhaled beta2-adrenoceptor agonist exerting a 24-hour-long duration of action in preclinical models.

Bouyssou T, Casarosa P, Naline E, Pestel S, Konetzki I, Devillier P, Schnapp A.

J Pharmacol Exp Ther · journal article · DOI 10.1124/jpet.110.167007

Bibliografisk träff 2010-01-04

Discovery of olodaterol, a novel inhaled beta2-adrenoceptor agonist with a 24 h bronchodilatory efficacy.

Bouyssou T, Hoenke C, Rudolf K, Lustenberger P, Pestel S, Sieger P, Lotz R, Heine C, Büttner FH, Schnapp A, Konetzki I.

Bioorg Med Chem Lett · journal article · DOI 10.1016/j.bmcl.2009.12.087